BTIG Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Maintains Target Price $100
GE Healthcare Technologies Inc's Flyrcado Gains Buy Rating Amid FDA Approval and Revenue Growth Potential
Goldman Sachs Adjusts Price Target on GE HealthCare Technologies to $91 From $88
Wells Fargo Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Maintains Target Price $95
Buy Rating for GE Healthcare Technologies Inc. on Flyrcado's Market Disruption Potential
GE Hlthcr Techs Is Maintained at Outperform by Evercore ISI Group
GE HealthCare Techs Analyst Ratings
Evercore Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Raises Target Price to $102
Stifel Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Raises Target Price to $102
Wells Fargo Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Maintains Target Price $95
GE HealthCare Techs Analyst Ratings
BTIG Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Maintains Target Price $100
BTIG Upgrades GE Healthcare Technologies Inc (GEHC) to a Buy
UBS Downgrades GE HealthCare Technologies(GEHC.US) to Sell Rating, Cuts Target Price to $74
Recommendation to Sell GE Healthcare Technologies Inc. Amid Overvaluation and Competitive Risks
BofA Securities Maintains GE HealthCare Technologies(GEHC.US) With Hold Rating, Raises Target Price to $97
GE Hlthcr Techs Price Target Announced at $100.00/Share by BTIG
GE HealthCare Techs Analyst Ratings
BTIG Upgrades GE HealthCare Technologies(GEHC.US) to Buy Rating, Announces Target Price $100
GE Healthcare Technologies Inc.: Strong Buy Rating on Back of Strategic Adjustments and Promising Outlook